サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631120

クリティカルケア診断の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 180 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
クリティカルケア診断の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年12月12日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

クリティカルケア診断市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のクリティカルケア診断市場規模は2030年までに21億米ドルに達する見込みです。

同市場は2025～2030年にかけてCAGR 6.11％で成長すると予測されています。この産業の成長を支える主要要因は、医師や患者によるこれらの検査に対する急速な認識と認知、高齢者と慢性的な健康状態の増加、遠隔地における遠隔医療サービスの採用、技術の進歩です。分子診断のコスト上昇と熟練労働者の不足は、産業の成長を阻害する要因であると予想されます。

クリティカルケア診断市場をタイプ別に分類すると、ルーチン化学・特殊化学、フローサイトメトリー、血液学、免疫タンパク質、微生物・感染症、凝固検査、その他に分類されます。微生物・感染症検査診断セグメントは、予測期間中のCAGRが7.24%を超え、最も高い成長率が予測されています。例えば、医療システムは病原体同定のための血液培養の収集と処理にかなりのリソースを費やしています。

核酸増幅検査のようなクリティカルケア診断検査は、臨床医がより迅速かつ正確に細菌を検出・同定することを可能にし、適切な抗菌薬治療を可能な限り迅速に開始し、回避可能な薬剤の使用を中止することを望む臨床医に指針を記載しています。最終用途によるクリティカルケア診断市場は、手術室、救急室、ICUに分類されます。予測期間中、最も高い成長率が見込まれるのは救急室セグメントです。

クリティカルケア診断市場レポートハイライト

  • アジア太平洋は予測期間中にCAGR 8.0%で最速の成長が見込まれます。高齢者の多さ、慢性疾患の有病率の増加、アジア太平洋における専門病院数の増加、農村部における医療サービスとインフラの改善が市場成長を促進する要因です。
  • クリティカルケア診断市場のタイプ別シェアでは、免疫タンパク質診断検査セグメントが最大を占めると推定されます。迅速かつ正確な予防医療サービスに対する需要の高まりが、この市場成長を促進する主要要因の1つです。
  • 最終用途別では、急性期医療患者の約20％がICUに入院しているのに対し、約58％が救急治療室に入院しています。救急治療室は、予測期間中に最も高いCAGRで飛躍的な成長が見込まれています。ERサービスに対する患者需要の最近の高まりは、初期急性期治療の診断と重症患者の治療を提供するERの能力によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場セグメンテーションと範囲
  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場動向と展望
  • 市場力学
  • 市場抑制要因分析
  • ビジネス環境分析
    • SWOT分析、要因別（政治・法律、経済技術）
    • ポーターのファイブフォース分析

第4章 タイプビジネス分析

  • クリティカルケア診断市場：タイプ変動分析
  • ルーチン化学・特殊化学
    • ルーチン化学・特殊化学市場、2018～2030年
  • フローサイトメトリー
    • フローサイトメトリー市場、2018～2030年
  • 血液学
    • 血液学市場、2018～2030年
  • 免疫タンパク質
    • 免疫タンパク質市場、2018～2030年
  • 微生物・感染症
    • 微生物・感染症市場、2018～2030年
  • 凝固検査
    • 凝固検査市場、2018～2030年
  • その他
    • その他市場、2018～2030年

第5章 最終用途ビジネス分析

  • クリティカルケア診断市場：最終用途変動分析
  • 手術室
    • 手術室市場、2018～2030年
  • 集中治療室
    • 集中治療室市場、2018～2030年
  • 救急室
    • 救急室市場、2018～2030年
  • その他
    • その他市場、2018～2030年

第6章 地域ビジネス分析

  • 地域別クリティカルケア診断市場シェア、2024年と2030年
  • 北米
    • 北米の集中治療診断市場、2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の重要診断市場、2018～2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋の救命救急診断市場、2018～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカ集中治療診断市場、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ重要診断市場、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業分類
  • 戦略マッピング
  • 企業市場シェア分析、2024年
  • 企業プロファイル/上場企業
    • Abbott
    • Danaher
    • Siemens Healthineers
    • F. Hoffmann-La Roche Ltd.
    • Quidel Corporation
    • bioMerieux SA
    • Chembio Diagnostics, Inc.
    • EKF Diagnostics
    • Bayer AG
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 5 Global Critical Care Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 North America Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 11 Mexico Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 Mexico Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 15 Europe Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 16 Europe Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Europe Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 18 Germany Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 19 Germany Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 20 UK Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 UK Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 22 France Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 France Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 24 Italy Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 Italy Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 Spain Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Spain Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 28 Denmark Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 29 Denmark Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 30 Sweden Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Sweden Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 32 Norway Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Norway Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 37 China Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 38 China Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 39 Japan Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 Japan Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 41 India Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 42 India Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 43 South Korea Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 44 South Korea Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Australia Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Australia Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 47 Thailand Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 48 Thailand Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 49 Latin America Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 50 Latin America Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Latin America Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 52 Brazil Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 Brazil Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 54 Argentina Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Argentina Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 59 South Africa Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 South Africa Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 63 UAE Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 UAE Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Critical Care Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Critical Care Diagnostics Market: Type Movement Analysis
  • Fig. 16 Global Critical Care Diagnostics Market, for Routine & Special Chemistry, 2018 - 2030 (USD Million)
  • Fig. 17 Global Critical Care Diagnostics Market, for Flow Cytometry, 2018 - 2030 (USD Million)
  • Fig. 18 Global Critical Care Diagnostics Market, for Hematology, 2018 - 2030 (USD Million)
  • Fig. 19 Global Critical Care Diagnostics Market, for Immunoproteins, 2018 - 2030 (USD Million)
  • Fig. 20 Global Critical Care Diagnostics Market, for Microbial & Infectious Disease, 2018 - 2030 (USD Million)
  • Fig. 21 Global Critical Care Diagnostics Market, for Coagulation Testing, 2018 - 2030 (USD Million)
  • Fig. 22 Global Critical Care Diagnostics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 23 Global Critical Care Diagnostics Market: End-use Movement Analysis
  • Fig. 24 Global Critical Care Diagnostics Market, for Operation Room, 2018 - 2030 (USD Million)
  • Fig. 25 Global Critical Care Diagnostics Market, for Intensive Care Unit, 2018 - 2030 (USD Million)
  • Fig. 26 Global Critical Care Diagnostics Market, for Emergency Rooms, 2018 - 2030 (USD Million)
  • Fig. 27 Global Critical Care Diagnostics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 28 Regional Marketplace: Key Takeaways
  • Fig. 29 Regional Outlook, 2024 & 2030
  • Fig. 30 Global Critical Care Diagnostics Market, Region Movement Analysis
  • Fig. 31 North America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 37 UK Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 38 France Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 46 China Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 47 India Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-010-1

Critical Care Diagnostics Market Growth & Trends:

The global critical care diagnostics market size is expected to reach USD 2.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 6.11% from 2025 to 2030. The key factors supporting the industry's growth comprise the rapid awareness and acknowledgment of these tests by physicians and patients, the rise in geriatric population and chronic health conditions, the employment of telehealth services in remote areas, and technological advancements. The increased cost of the molecular diagnostics and dearth of skilled labor are factors that are expected to hinder the growth of the industry.

The critical care diagnostics market by type is categorized into routine and special chemistry, flow cytometry, hematology, immunoproteins, microbial and infectious diseases, coagulation testing, and others. The microbial and infectious diseases test diagnostics segment is projected to grow at the highest rate with a CAGR of over 7.24% during the forecast period. For example, healthcare systems spend a substantial amount of resources in the collection and processing of blood cultures for the identification of pathogens.

Critical care diagnostic tests, such as the nucleic acid amplification test, allow clinicians to detect and identify organisms more rapidly and accurately and provide guidance to clinicians, who aspire to commence the appropriate antimicrobial therapy as fast as possible and terminate the use of avoidable drugs. The critical care diagnostic market by the end-user is categorized into operation rooms, emergency rooms, and ICU's. The emergency rooms segment in the industry is anticipated to witness the highest growth rate during the forecast period.

Critical Care Diagnostics Market Report Highlights:

  • The Asia Pacific region is expected to grow at the fastest CAGR of 8.0% during the forecast period. The large presence of geriatric population, increasing prevalence of chronic diseases, increase in the number of specialty hospitals in the Asia Pacific region, and improving healthcare services and infrastructures in rural areas are the factors fueling the market growth.
  • The immunoproteins diagnostic test segment is estimated to account for the largest share of the critical care diagnostic market by type. The rise in demand for rapid and accurate preventive healthcare services is one of the major factors driving this market growth.
  • On the basis of end-users, approximately 20% of acute-care patients get admitted into ICU's, whereas nearly 58% get admitted into emergency rooms. The emergency rooms are expected to witness exponential growth with the highest CAGR during the forecast period. The recent rise in the patient demand for ER services is due to its ability to provide initial acute care diagnosis and treatment of critically ill patients.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Type Business Analysis

  • 4.1. Critical Care Diagnostics Market: Type Movement Analysis
  • 4.2. Routine & Special Chemistry
    • 4.2.1. Routine & Special Chemistry Market, 2018 - 2030 (USD Million)
  • 4.3. Flow Cytometry
    • 4.3.1. Flow Cytometry Market, 2018 - 2030 (USD Million)
  • 4.4. Hematology
    • 4.4.1. Hematology Market, 2018 - 2030 (USD Million)
  • 4.5. Immunoproteins
    • 4.5.1. Immunoproteins Market, 2018 - 2030 (USD Million)
  • 4.6. Microbial & Infectious Disease
    • 4.6.1. Microbial & Infectious Disease Market, 2018 - 2030 (USD Million)
  • 4.7. Coagulation Testing
    • 4.7.1. Coagulation Testing Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End-use Business Analysis

  • 5.1. Critical Care Diagnostics Market: End-use Movement Analysis
  • 5.2. Operation Room
    • 5.2.1. Operation Room Market, 2018 - 2030 (USD Million)
  • 5.3. Intensive Care Unit
    • 5.3.1. Intensive Care Unit Market, 2018 - 2030 (USD Million)
  • 5.4. Emergency Rooms
    • 5.4.1. Emergency Rooms Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Critical Care Diagnostics Market Share By Region, 2024 & 2030
  • 6.2. North America
    • 6.2.1. North America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Target Disease Prevalence
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. Regulatory Framework
      • 6.2.2.5. Reimbursement Scenario
      • 6.2.2.6. U.S. Critical Care Diagnostics Market, 2018 - 2030 (USD MILLION)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Target Disease Prevalence
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Regulatory Framework
      • 6.2.3.5. Reimbursement Scenario
      • 6.2.3.6. Canada Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Target Disease Prevalence
      • 6.2.4.3. Competitive Scenario
      • 6.2.4.4. Regulatory Framework
      • 6.2.4.5. Reimbursement Scenario
      • 6.2.4.6. Mexico Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Critical diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Target Disease Prevalence
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. Regulatory Framework
      • 6.3.2.5. Reimbursement Scenario
      • 6.3.2.6. Germany Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Target Disease Prevalence
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Regulatory Framework
      • 6.3.3.5. Reimbursement Scenario
      • 6.3.3.6. UK Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Target Disease Prevalence
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. Regulatory Framework
      • 6.3.4.5. Reimbursement Scenario
      • 6.3.4.6. France Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Target Disease Prevalence
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Regulatory Framework
      • 6.3.5.5. Reimbursement Scenario
      • 6.3.5.6. Italy Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Target Disease Prevalence
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Regulatory Framework
      • 6.3.6.5. Reimbursement Scenario
      • 6.3.6.6. Spain Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Target Disease Prevalence
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Regulatory Framework
      • 6.3.7.5. Reimbursement Scenario
      • 6.3.7.6. Denmark Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Target Disease Prevalence
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Regulatory Framework
      • 6.3.8.5. Reimbursement Scenario
      • 6.3.8.6. Sweden Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Target Disease Prevalence
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Regulatory Framework
      • 6.3.9.5. Reimbursement Scenario
      • 6.3.9.6. Norway Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Regulatory Framework
      • 6.4.2.5. Reimbursement Scenario
      • 6.4.2.6. Japan Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Regulatory Framework
      • 6.4.3.5. Reimbursement Scenario
      • 6.4.3.6. China Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. Regulatory Framework
      • 6.4.4.5. Reimbursement Scenario
      • 6.4.4.6. India Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Target Disease Prevalence
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Regulatory Framework
      • 6.4.5.5. Reimbursement Scenario
      • 6.4.5.6. South Korea Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Target Disease Prevalence
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Regulatory Framework
      • 6.4.6.5. Reimbursement Scenario
      • 6.4.6.6. Australia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Target Disease Prevalence
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Regulatory Framework
      • 6.4.7.5. Reimbursement Scenario
      • 6.4.7.6. Thailand Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Regulatory Framework
      • 6.5.2.5. Reimbursement Scenario
      • 6.5.2.6. Brazil Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Regulatory Framework
      • 6.5.3.5. Reimbursement Scenario
      • 6.5.3.6. Argentina Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Critical diagnostics Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Regulatory Framework
      • 6.6.2.5. Reimbursement Scenario
      • 6.6.2.6. South Africa Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Regulatory Framework
      • 6.6.3.5. Reimbursement Scenario
      • 6.6.3.6. Saudi Arabia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Regulatory Framework
      • 6.6.4.5. Reimbursement Scenario
      • 6.6.4.6. UAE Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Regulatory Framework
      • 6.6.5.5. Reimbursement Scenario
      • 6.6.5.6. Kuwait Critical Care Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Abbott
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Collection Site Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Danaher
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Collection Site Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Siemens Healthineers
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Collection Site Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. F. Hoffmann-La Roche Ltd.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Collection Site Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Quidel Corporation
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Collection Site Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. bioMerieux S.A
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Collection Site Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Chembio Diagnostics, Inc.
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Collection Site Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. EKF Diagnostics
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Collection Site Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Bayer AG
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Collection Site Benchmarking
      • 7.4.9.4. Strategic Initiatives